HomeSuppliersGenomeMe Lab Inc
Canada

GenomeMe Lab Inc Verified partner

GenomeMe is a biotechnology company specializing in immunohistochemistry (IHC) monoclonal antibodies and molecular diagnostic tools for cancer research and clinical applications

GenomeMe Lab Inc. is a Canada-based biotechnology company founded around 2015, focused on developing molecular diagnostic tools and high-quality antibodies for clinical and research applications.

More detail +

The company specializes in immunohistochemistry (IHC) monoclonal antibodies, particularly mouse and rabbit-derived antibodies designed for cancer diagnostics and pathology workflows.

GenomeMe differentiates itself by developing and manufacturing its antibodies entirely in-house, enabling strong control over quality, cost, and reproducibility.

Its portfolio includes over 260+ clinical IHC antibodies, with ongoing expansion into molecular diagnostics such as qPCR-based cancer detection kits.

The company is actively positioned in the growing field of precision diagnostics and molecular pathology, serving hospitals, diagnostic labs, and research institutions

ISO 13485
GenomeMe Lab Inc
6
Product lines
Canada
Origin
Canada · Ships worldwide via BioHippo
Why work with them

What makes GenomeMe Lab Inc different

IHC antibodies for cancer diagnostics

GenomeMe specializes in immunohistochemistry monoclonal antibodies for cancer diagnostics and pathology.

More detail +

Its mouse and rabbit-derived antibodies are designed for pathology workflows, with a portfolio of more than 260 clinical IHC antibodies used by hospitals and diagnostic labs.

In-house antibody development

GenomeMe develops and manufactures its antibodies entirely in-house.

More detail +

This vertical control over the process supports consistent quality, cost, and reproducibility across its clinical and research antibody portfolio.

Expansion into molecular diagnostics

Beyond antibodies, GenomeMe is expanding into molecular diagnostic tools.

More detail +

Ongoing development includes qPCR-based cancer detection kits, positioning the company in precision diagnostics and molecular pathology for hospitals, diagnostic labs, and research institutions.

Key techniques

Where they're strong

GenomeMe products support clinical and research workflows focused on pathology, cancer diagnostics, and molecular testing

Immunohistochemistry (IHC)qPCR (Quantitative PCR)Molecular DiagnosticsWestern Blot (WB)ImmunoassaysBiomarker DetectionPathology Staining
Catalog scope

Product lines & services

GenomeMe offers a focused portfolio of diagnostic antibodies and molecular testing tools for clinical and research applications

Quality & logistics

QC, documentation & shipping

Quality control & documentation

GenomeMe provides clinical-grade validation and documentation for its diagnostic products

Quality control
Performed & documented
IHC mouse and rabbit monoclonal antibodies are validated on tissue with matched controls; qPCR diagnostic kits are verified for sensitivity and specificity.
Antibody datasheets list clone, staining pattern and validated dilutions; molecular kits include performance specifications.
Quality system certified to ISO 13485; cancer-biomarker clones include additional documentation.
Documentation
Available on request
Certificate of Analysis MSDS / SDS HPLC report Quality Policy

Lead time & shipping

Shipping timelines depend on product availability and customization

In-stock IHC antibodies and qPCR kits ship from Canada; custom and bulk orders follow quoted timelines.
Temperature-controlled shipping for antibodies and molecular diagnostic kits.

Request a quote from GenomeMe Lab Inc

Tell us your target and application — a BioHippo scientist will shortlist options and pricing, usually within one business day.

One vendor, one PO — sourced through BioHippo
COA / MSDS / QC on request
Bulk & custom pricing available